Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-06

Clinical Trial Update: Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis [NA]

View source ↗

Summary

AdventHealth's clinical trial evaluating fluorescence imaging with indocyanine green dye for visual diagnosis of endometriosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: AdventHealth | Conditions: Endometriosis | NA | Status: TERMINATED